Honors the contributions of clinical trial participants.
[Congressional Bills 110th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 248 Introduced in House (IH)]
110th CONGRESS
1st Session
H. RES. 248
Honoring the contributions of patient participants in clinical trials.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
March 15, 2007
Mr. Boucher (for himself and Mr. Cannon) submitted the following
resolution; which was referred to the Committee on Energy and Commerce
_______________________________________________________________________
RESOLUTION
Honoring the contributions of patient participants in clinical trials.
Whereas clinical trials of new medicines and vaccines are vital to advancing
science and conquering disease;
Whereas a clinical trial is a scientific test of the effectiveness and safety of
a new medicine or vaccine with the consent of human volunteers,
providing invaluable information to medical researchers and physicians;
Whereas over 2,300,000 people enable medical advances by actively participating
in nearly 80,000 clinical trials every year in the United States;
Whereas participants join clinical trials in order to help find better ways to
prevent, detect, diagnose, or treat illnesses and to improve medicines;
Whereas every patient using a medicine greatly benefits from essential knowledge
of safety and effectiveness possible only through the contribution of
clinical trial volunteers;
Whereas clinical trial volunteers are credited with helping to develop the
treatments that have cut the death rate of heart disease by 50 percent;
Whereas 20 percent of all participants in trials of new medicines are over the
age of 65, creating invaluable knowledge about the unique needs of
seniors;
Whereas over 60 percent of children with cancer are enrolled in clinical trials,
offering hope to children and their families across America;
Whereas 41 percent of eligible AIDS patients participate in cooperative studies,
enabling continued progress in the effort to defeat this disease;
Whereas 80 percent of all eligible lung cancer patients are enrolled in a
clinical trial, allowing new generations of medicines to advance against
a disease that has not previously had effective treatments;
Whereas the contributions of clinical trial participants have led to the
discovery of new treatments and cures and an improved quality of life
for all; and
Whereas clinical trial volunteers are needed now more than ever to enable
advances against conditions like Alzheimer's, which will exact an
incalculable human and economic cost as baby boomers become seniors
unless effective and safe new treatments are developed: Now, therefore,
be it
Resolved, That the House of Representatives--
(1) honors and recognizes the sacrifice, commitment, and
contributions of clinical trial participants; and
(2) encourages everyone to learn about the importance of
clinical trials and the important role of trial participants.
<all>
Introduced in House
Introduced in House
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.
Llama 3.2 · runs locally in your browser
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line